If your cholesterol suddenly starts creeping up in your 40s or 50s, it may not be just your diet.

The menopause transition is associated with important changes in cardiovascular health, including changes in cholesterol, blood sugar, body composition, blood pressure, and other factors that influence long-term heart disease risk.

In fact, a 2026 study published in the Journal of the American Heart Association found that women in perimenopause were about twice as likely to have poorer overall cardiovascular health compared with premenopausal women. Higher cholesterol and blood sugar were major contributors.

In this video, I explain:

• Why cholesterol can change during perimenopause and menopause
• Why cardiovascular risk deserves more attention in women after 40
• What women should be monitoring during midlife
• How exercise, nutrition, sleep, blood pressure, glucose, and other modifiable factors can protect your heart
• What we currently know about menopausal hormone therapy (HRT) and cardiovascular health
• Why the timing of hormone therapy matters

Hormone therapy is not recommended solely for the prevention of cardiovascular disease, but research suggests that cardiovascular outcomes differ depending on when therapy is initiated. For healthy women with bothersome menopausal symptoms who begin hormone therapy younger than age 60 or within approximately 10 years of menopause, the overall benefit-risk profile is generally more favorable than when therapy is initiated later.

As a primary care nurse practitioner who has spent years caring for adults and older adults, I think midlife represents an important opportunity to identify cardiovascular risk factors early—before they become cardiovascular disease later in life.

Menopause isn't only about managing symptoms. It's also an opportunity to think about how we want to age.

This video is for educational purposes only and does not replace individualized medical care.

Maira Luettinger, DNP, APRN, AGPCNP-BC
Founder, MIDVI Health
Primary Care • Midlife & Menopause • Healthy Aging

Your labs are “normal”… but you’re exhausted, gaining weight, sleeping poorly, and you just don’t feel like yourself.

Could it still be perimenopause? In my newest YouTube video, I walk through how I think about this common scenario as a primary care nurse practitioner. Because yes—perimenopause may be part of the picture. But we shouldn’t blame every symptom a woman experiences in her 40s on hormones.

We’ll talk about:

• Why normal hormone labs don’t rule out perimenopause

• Thyroid disease, anemia and iron deficiency

• Sleep and mental health

• Midlife weight and body-composition changes

• Muscle and metabolic health • When hormone therapy may—or may not—be appropriate

• Why your health in your 40s and 50s matters for how you age

Midlife isn’t just something we need to get women through. It’s an opportunity to identify risks early and change the trajectory of health.

Randomized trials have demonstrated that menopausal hormone therapy significantly preserves bone mineral density and reduces vertebral, hip, and overall osteoporotic fractures.

In the Women's Health Initiative, combined estrogen-progestin therapy reduced hip fractures by 34% and total fractures by 24%, while meta-analyses demonstrate reductions in vertebral and osteoporotic fractures ranging from approximately 20% to 50%, depending on fracture type and patient population.

Cauley JA, et al. JAMA. 2003;290:1729-1738. The Menopause Society. The 2022 Hormone Therapy Position Statement. Menopause. 2022. International Osteoporosis Foundation. MHT and fracture prevention. Lobo RA, et al. Prevention of diseases after menopause. Am J Med. 2014.

In this video, I review key clinical concepts from Menopause Practice: A Clinician’s Guide by The Menopause Society, focusing on Genitourinary Syndrome of Menopause (GSM)—a collection of menopausal symptoms caused by estrogen changes affecting the vulva, vagina, urinary tract, and sexual health.

Topics discussed include:

• What GSM is and why it is more than “vaginal dryness”

• Common symptoms: dryness, irritation, painful intercourse, urinary symptoms, and recurrent UTIs

• Why GSM often goes unrecognized and untreated

• Evidence-based treatment options and the importance of individualized care

GSM is a chronic condition that can significantly impact quality of life, but effective treatments are available. Clinicians play an important role in creating a safe space for conversations about symptoms that many patients hesitate to discuss.

Reference:

The Menopause Society. Menopause Practice: A Clinician’s Guide, 6th Edition. The NAMS 2020 Genitourinary Syndrome of Menopause Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992. doi:10.1097/GME.0000000000001609.

Educational content only and not a substitute for personalized medical advice. If you have symptoms of GSM, discuss evaluation and treatment options with your healthcare provider.

Hair loss in midlife is common, it's not your fault, and most importantly — it's treatable. A simple set of blood tests and the right treatment plan can make a real difference. Talk to your doctor, be patient with the process, and know that you're not alone in this.

This content is for educational purposes only.

Does hormone replacement therapy (HRT) increase your risk of breast cancer?

It’s one of the biggest concerns women have when considering hormone therapy for perimenopause and menopause — and the answer is much more nuanced than a simple yes or no.

In this video, I break down what The Menopause Society and the Women’s Health Initiative (WHI) evidence actually tell us about menopausal hormone therapy and breast cancer.

We discuss:

• Why estrogen alone is different from estrogen + progestogen

• What the WHI found about breast cancer incidence and mortality • Why the type and duration of hormone therapy matter

• What we know — and don’t yet know — about micronized progesterone • Why absolute risk and your individual baseline risk matter

• Why hormone therapy should be individualized rather than viewed as simply “safe” or “dangerous”

One particularly important finding: in long-term follow-up of the WHI randomized trials, women with prior hysterectomy who received conjugated equine estrogen alone had significantly lower breast cancer incidence and mortality than those receiving placebo.

In contrast, conjugated equine estrogen plus medroxyprogesterone acetate was associated with higher breast cancer incidence. That does not mean estrogen prevents breast cancer or that hormone therapy is appropriate for everyone. It demonstrates why we cannot treat every form of menopausal hormone therapy as though it carries the same risk.

The goal isn’t to convince every woman to take hormones. It’s to give women accurate information so they can make an informed decision with a knowledgeable healthcare professional.

SOURCES

The Menopause Society. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022. Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of

Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA. 2020;324(4):369–380. doi:10.1001/jama.2020.9482 Rossouw JE, Anderson GL, Prentice RL, et al. Risks and Benefits of Estrogen Plus Progestin in Healthy

Postmenopausal Women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial. JAMA. 2002;288(3):321–333. This content is for educational purposes only and is not a substitute for individualized medical advice.

The menopause transition is an important time for body composition. Research has shown that lean mass can decline while fat mass increases during this stage of life. And muscle isn’t just about looking strong — it plays an important role in metabolism, bone health, balance, physical function, and maintaining independence as we age.

In this video, I explain:

• Why muscle and body composition change during midlife

• How menopause and aging may contribute

• Why the scale doesn’t tell the whole story

• Why strength training becomes increasingly important

• The role of adequate dietary protein

• Why preserving muscle matters during weight loss, including when using GLP-1 medications

• What we know about creatine and muscle health

• Why building strength in your 40s and 50s is an investment in healthy aging One of the most important things we can do in midlife is stop thinking about exercise only as a way to burn calories. We should be training for the body we want to have at 70, 80 and beyond.